1	Chronic	chronic	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
4	virus	virus	_	_	_	_	_	_	_
5	type	type	_	_	_	_	_	_	_
6	1	1	_	_	_	_	_	_	_
7	infection	infection	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	myeloid	myeloid	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	disrupts	disrupt	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	autoregulatory	autoregulatory	_	_	_	_	_	_	_
14	control	control	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	NF-kappaB/Rel	NF-kappaB/Rel	_	_	_	_	_	_	_
18	pathway	pathway	_	_	_	_	_	_	_
19	via	via	_	_	_	_	_	_	_
20	enhanced	enhance	_	_	_	_	_	_	_
21	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
22	degradation	degradation	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Productive	productive	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
4	virus	virus	_	_	_	_	_	_	_
5	type	type	_	_	_	_	_	_	_
6	1	1	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	HIV-1	HIV-1	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	infection	infection	_	_	_	_	_	_	_
11	causes	cause	_	_	_	_	_	_	_
12	sustained	sustained	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	DNA-binding	dna-binding	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	chronically	chronically	_	_	_	_	_	_	_
18	infected	infected	_	_	_	_	_	_	_
19	monocytic	monocytic	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	direct	direct	_	_	_	_	_	_	_
3	temporal	temporal	_	_	_	_	_	_	_
4	correlation	correlation	_	_	_	_	_	_	_
5	exists	exist	_	_	_	_	_	_	_
6	between	between	_	_	_	_	_	_	_
7	HIV	HIV	_	_	_	_	_	_	_
8	infection	infection	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	appearance	appearance	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	DNA-binding	dna-binding	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	myelomonoblastic	myelomonoblastic	_	_	_	_	_	_	_
18	PLB-985	plb-985	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	examine	examine	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	molecular	molecular	_	_	_	_	_	_	_
5	basis	basis	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	constitutive	constitutive	_	_	_	_	_	_	_
8	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
9	DNA-binding	dna-binding	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	HIV1	hiv1	_	_	_	_	_	_	_
13	-infected	-infected	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	we	we	_	_	_	_	_	_	_
17	analyzed	analyze	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	phosphorylation	phosphorylation	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	turnover	turnover	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
24	protein	protein	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	activity	activity	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	double-stranded	double-stranded	_	_	_	_	_	_	_
31	RNA-dependent	rna-dependent	_	_	_	_	_	_	_
32	protein	protein	_	_	_	_	_	_	_
33	kinase	kinase	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	PKR	PKR	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	intracellular	intracellular	_	_	_	_	_	_	_
40	levels	level	_	_	_	_	_	_	_
41	of	of	_	_	_	_	_	_	_
42	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
43	subunits	subunit	_	_	_	_	_	_	_
44	in	in	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	PLB-985	PLB-985	_	_	_	_	_	_	_
47	and	and	_	_	_	_	_	_	_
48	U937	u937	_	_	_	_	_	_	_
49	myeloid	myeloid	_	_	_	_	_	_	_
50	cell	cell	_	_	_	_	_	_	_
51	models	model	_	_	_	_	_	_	_
52	.	.	_	_	_	_	_	_	_

1	HIV-1	HIV-1	_	_	_	_	_	_	_
2	infection	infection	_	_	_	_	_	_	_
3	resulted	result	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	constitutive	constitutive	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	low-level	low-level	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	type	type	_	_	_	_	_	_	_
11	1	1	_	_	_	_	_	_	_
12	interferon	interferon	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	IFN	IFN	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	at	at	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	mRNA	mrna	_	_	_	_	_	_	_
19	level	level	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	PKR	PKR	_	_	_	_	_	_	_
3	activity	activity	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	also	also	_	_	_	_	_	_	_
6	detected	detect	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	result	result	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	low-level	low-level	_	_	_	_	_	_	_
15	IFN	IFN	_	_	_	_	_	_	_
16	production	production	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	since	since	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	addition	addition	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	anti-IFN-alpha/beta	anti-ifn-alpha/beta	_	_	_	_	_	_	_
23	antibody	antibody	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	decreased	decrease	_	_	_	_	_	_	_
28	PKR	pkr	_	_	_	_	_	_	_
29	expression	expression	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	analysis	analysis	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
7	turnover	turnover	_	_	_	_	_	_	_
8	demonstrated	demonstrate	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	increased	increase	_	_	_	_	_	_	_
11	degradation	degradation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	may	may	_	_	_	_	_	_	_
19	account	account	_	_	_	_	_	_	_
20	for	for	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	constitutive	constitutive	_	_	_	_	_	_	_
23	DNA	dna	_	_	_	_	_	_	_
24	binding	binding	_	_	_	_	_	_	_
25	activity	activity	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	dramatic	dramatic	_	_	_	_	_	_	_
3	increase	increase	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	intracellular	intracellular	_	_	_	_	_	_	_
7	levels	level	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
10	subunits	subunit	_	_	_	_	_	_	_
11	c-Rel	c-rel	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	NF-kappaB2	nf-kappab2	_	_	_	_	_	_	_
14	p100	p100	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	moderate	moderate	_	_	_	_	_	_	_
18	increase	increase	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	NF-kappaB2	NF-kappaB2	_	_	_	_	_	_	_
21	p52	p52	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	RelA(p65)	RelA(p65)	_	_	_	_	_	_	_
24	were	be	_	_	_	_	_	_	_
25	detected	detect	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	whereas	whereas	_	_	_	_	_	_	_
31	NF-kappaB1	nf-kappab1	_	_	_	_	_	_	_
32	p105/p50	p105/p50	_	_	_	_	_	_	_
33	levels	level	_	_	_	_	_	_	_
34	were	be	_	_	_	_	_	_	_
35	not	not	_	_	_	_	_	_	_
36	altered	alter	_	_	_	_	_	_	_
37	relative	relative	_	_	_	_	_	_	_
38	to	to	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	levels	level	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	uninfected	uninfected	_	_	_	_	_	_	_
43	cells	cell	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	suggest	suggest	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	HIV-1	HIV-1	_	_	_	_	_	_	_
5	infection	infection	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	myeloid	myeloid	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	induces	induce	_	_	_	_	_	_	_
10	IFN	ifn	_	_	_	_	_	_	_
11	production	production	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	PKR	pkr	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	which	which	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	turn	turn	_	_	_	_	_	_	_
19	contribute	contribute	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	enhanced	enhance	_	_	_	_	_	_	_
22	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
23	phosphorylation	phosphorylation	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	subsequent	subsequent	_	_	_	_	_	_	_
26	degradation	degradation	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	translocation	translocation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	subunits	subunit	_	_	_	_	_	_	_
6	may	may	_	_	_	_	_	_	_
7	ultimately	ultimately	_	_	_	_	_	_	_
8	increase	increase	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	intracellular	intracellular	_	_	_	_	_	_	_
11	pool	pool	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappaB/IkappaBalpha	NF-kappaB/IkappaBalpha	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	autoregulatory	autoregulatory	_	_	_	_	_	_	_
17	mechanism	mechanism	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Enhanced	enhance	_	_	_	_	_	_	_
2	turnover	turnover	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	accumulation	accumulation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	NF-kappaB/Rel	NF-kappaB/Rel	_	_	_	_	_	_	_
10	proteins	protein	_	_	_	_	_	_	_
11	may	may	_	_	_	_	_	_	_
12	contribute	contribute	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	chronically	chronically	_	_	_	_	_	_	_
16	activated	activate	_	_	_	_	_	_	_
17	state	state	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

